Steel Peak Wealth Management LLC bought a new position in shares of iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 9,822 shares of the financial services provider’s stock, valued at approximately $1,184,000.
Other large investors have also bought and sold shares of the company. Janney Capital Management LLC purchased a new position in iShares Nasdaq Biotechnology ETF in the fourth quarter valued at about $23,078,000. Tower Research Capital LLC TRC lifted its stake in shares of iShares Nasdaq Biotechnology ETF by 86,314.0% during the 3rd quarter. Tower Research Capital LLC TRC now owns 135,670 shares of the financial services provider’s stock valued at $13,499,000 after buying an additional 135,513 shares in the last quarter. Estate Counselors LLC purchased a new stake in shares of iShares Nasdaq Biotechnology ETF during the 4th quarter valued at approximately $12,713,000. CHURCHILL MANAGEMENT Corp purchased a new stake in shares of iShares Nasdaq Biotechnology ETF during the 4th quarter valued at approximately $5,451,000. Finally, Virtu Financial LLC purchased a new stake in shares of iShares Nasdaq Biotechnology ETF during the 3rd quarter valued at approximately $4,400,000. 84.58% of the stock is owned by institutional investors.
Separately, ValuEngine cut shares of iShares Nasdaq Biotechnology ETF from a “buy” rating to a “hold” rating in a research note on Tuesday, October 22nd.
Shares of IBB stock traded up $0.42 during trading on Friday, reaching $122.37. 1,117,949 shares of the company’s stock traded hands, compared to its average volume of 2,972,001. The firm’s 50-day moving average is $119.79 and its 200 day moving average is $110.99. iShares Nasdaq Biotechnology ETF has a 1 year low of $96.03 and a 1 year high of $123.74.
iShares Nasdaq Biotechnology ETF Profile
iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.
Featured Article: Monthly Dividend Stocks Can Provide Solid Income
Want to see what other hedge funds are holding IBB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for iShares Nasdaq Biotechnology ETF (NASDAQ:IBB).
Receive News & Ratings for iShares Nasdaq Biotechnology ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares Nasdaq Biotechnology ETF and related companies with MarketBeat.com's FREE daily email newsletter.